March is a transition point in global public health.
Winter respiratory seasons are being evaluated, early signals for spring and summer risks begin to emerge, and new surveillance data helps shape decisions for the months ahead.
Here are several developments that deserve attention this month.
Respiratory viruses remain a key focus.
Recent updates from the World Health Organization and the European Centre for Disease Prevention and Control indicate that influenza activity in the Northern Hemisphere is beginning to stabilize in some regions, while still placing pressure on healthcare systems in others.
At the same time, SARS-CoV-2 continues to circulate at lower but persistent levels, reinforcing the importance of integrated respiratory surveillance rather than pathogen-specific monitoring.
Another area to watch is measles.
Several countries across different regions have reported outbreaks in recent months, often linked to gaps in vaccination coverage. March data will be critical in determining whether these outbreaks remain localized or signal broader immunity challenges.
Polio surveillance remains ongoing.
According to updates reviewed by the World Health Organization International Health Regulations (IHR) Emergency Committee, both wild poliovirus and circulating vaccine-derived poliovirus continue to be detected in multiple regions.
This serves as a reminder that eradication efforts require sustained global coordination and high immunization coverage.
Vector-borne diseases are also entering the seasonal planning phase.
As temperatures begin to rise in some regions, public health systems are preparing for potential increases in diseases such as dengue. Early preparedness—vector control, surveillance strengthening, and risk communication—remains critical.
Finally, March is marked by World TB Day.
Each year, this moment brings renewed attention to tuberculosis, one of the world’s leading infectious disease killers. Updated data and policy discussions released around this date often shape funding priorities and intervention strategies globally.
March is not just about monitoring.
It is about interpreting signals early enough to act.